American Journal of Psychiatry Audio - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

American Journal of Psychiatry Audio — Government & Organizations
American Journal of Psychiatry Audio

Each episode of AJP Audio brings you an in-depth look at one of the articles featured in that month’s issue of The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Wide-ranging interviews with article authors cover the background, rationale, main findings, and future implications of the research.

This podcast is subject to the Terms of Use at ww.psychiatry.org. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent the views of the American Psychiatric Association, its officers, trustees, or members. The content of this podcast is provided for general informational purposes only and is not intended as, and shall not be understood or construed as, medical or any other type of professional advice nor does it represent any statement of the standard of care. We strongly recommend that any listener follow the advice of physicians directly involved in their care and contact their local emergency response number for any medical emergency. The information within this podcast is provided as-is and is not guaranteed to be correct, complete, or accurate.

Copyright: © Copyright 2020 American Psychiatric Association

Latest Episodes:

October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions Oct 01, 2026

Show notes

Dr. Charles Conway (Washington University School of Medicine, St. Louis) joins the podcast to discuss the RECOVER trial, a RCT that looked at vagus nerve stimulation and its effects on profoundly treatment resistant depression. Following that, AJP Editor-in-Chief Dr. Ned Kalin is joined by the October issue guest editor, Dr. William McDonald (Emory University, Atlanta) to discuss the rest of the October issue, which focuses on neuromodulation and precision therapeutics.

00:42 Conway interview
02:34 Quality of life
05:13 Ethical considerations of a sham arm in this population
07:00 Timing and VNS treatment
08:03 Clinical implications
09:02 Limitations
10:12 Further research
11:30 McDonald and Kalin interview
13:50 Song et al.
14:08 Li et al.
15:44 Donnery et al.
16:38 Valiengo et al.
17:28 Rush
20:03 Mahmoudi
22:37 Conway et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

September 2026: Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial Sep 01, 2026

Show notes

Dr. Heon-Jeong Lee (Korea University, Seoul) joins AJP Audio to discuss an app-based intervention designed to help individuals with mood disorders regulate their circadian rhythms to prevent recurrence of mood episodes. Afterwards, Dr. Ned Kalin will join us again to discuss the rest of the September issue of the Journal, which takes a close look at clinical treatment.

00:44 Findings
01:42 How the app works
03:05 Differences between the app and traditional lifestyle advice
04:14 Ethics surrounding shame treatment arms
05:43 Broader applicability of the intervention
06:50 Limitations
08:19 Immediate clinical implications
09:33 Further research
10:08 Kalin interview
10:27 Yeom et al.
16:02 Schacht et al.
20:31 Khosravani et al.
24:52 Peterson et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

August 2026: Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure Aug 01, 2026

Show notes

Dr. Deepak Cyril D'Souza (Yale University School of Medicine) joins the podcast to discuss a study looking at two cohorts of patients hospitalized with first instances of psychosis, one with cannabis exposure and one without. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the August issue of the Journal, which takes a look at issues surrounding schizophrenia spectrum disorder, from the clinical to basic science.

00:40 D'Souza interview
02:38 Subtyping and schizophrenia spectrum disorder
04:19 Relapse and long-term implications for cannabis induced psychosis
05:43 Improvements in cognition
08:03 Differences between the groups
09:26 Greater access and greater potency of cannabis products
11:29 Further research
13:45 Kalin interview
13:59 D'Souza et al.
21:34 Forsyth et al.
27:36 Enwright et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

July 2026: Social Determinants of Health in Psychiatric Disorders: Exciting Opportunities for Biopsychosocial Research and Clinical Care Jul 01, 2026

Show notes

Dr. Dilip Jeste (Social Determinants of Health Network, La Jolla, CA) joins the podcast to discuss how social determinants of health interact with treatment for psychiatric disorders. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin once again puts the rest of the July issue into context.

00:31 Impacts of social determinants of health on psychiatric disorders, research, and clinical care
04:43 Health related social needs versus social determinants of health
08:47 Loneliness as a risk factor
12:36 A clinician's role in societal factors
14:47 Mechanistic understandings social determinants and the exposome
18:17 Further research
22:25 Kalin interview
22:30 Jeste and Gyan
23:33 Blundell et al.
28:03 Yang et al.
32:20 Van der Meer et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial Jun 01, 2026

Show notes

Dr. Jason Tucciarone and Dr. Alan Schatzberg (Stanford University, Stanford, CA) join AJP Audio to discuss the use of low-dose buprenorphine as an adjunctive therapy to extend the anti-suicidal effects of ketamine treatment in patients with major depressive disorder and suicidal ideation. AJP Editor-in-Chief Dr. Ned Kalin joins to discuss the rest of the June issue of the Journal, which takes a close look at issues surrounding suicide and severe depression.

01:20 Tucciarone and Schatzberg interview
03:36 Disparity between effects on suicidal ideation and antidepressant ratings
05:36 Ethics of placebo and ketamine in patients with suicidal ideation
08:28 Immediate clinical implications
11:40 Limitations
14:10 Further research
16:19 Kalin interview
16:24 Tucciarone et al.
20:39 Rovers et al.
24:30 Jelen et al.

Board-certified psychiatrists, if you're seeking meaningful inpatient work with real clinical autonomy, consider becoming the Clinical Director for a 16-bed behavioral health hospital in Fergus Falls or Bemidji, Minnesota. You'll lead a supportive interdisciplinary team, enjoy predictable work-life balance, and have opportunities for teaching and mentorship without RVU pressure or third-party billing. Learn more on APA's Career Center, JobCentral, by searching Direct Care and Treatment – State of Minnesota.

Direct Care and Treatment – State of Minnesota: bit.ly/DCTClinicalDirector

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

Special Episode: The Future of DSM May 15, 2026

Show notes

In this special episode of AJP Audio, AJP Editor-in-Chief Dr. Ned Kalin is joined by Dr. María Oquendo (Perelman School of Medicine at the University of Pennsylvania, Philadelphia), chair of APA's Future DSM Strategic Committee to discuss a series of commentaries published in the May issue of the Journal discussing the strategic vision for the future of DSM.

00:39 Oquendo interview
03:07 Size of the response
04:18 Feedback
06:04 Incorporating the feedback
07:57 Emphasizing science with a title change for DSM
10:18 A living document
12:35 Changes from previous versions of DSM
16:08 Changes in documentation and coding
18:51 Lived experience
20:02 Working with AJP

Links to the commentaries:

Initial Strategy for the Future of DSMMaría A. Oquendo, M.D., Ph.D., et al.
The Future of DSM: A Report From the Structure and Dimensions SubcommitteeDost Öngür, M.D., Ph.D., et al.
The Future of DSM: Are Functioning and Quality of Life Essential Elements of a Complete Psychiatric Diagnosis?Karen Drexler, M.D., et al.
The Future of DSM: Role of Candidate Biomarkers and Biological FactorsBruce Cuthbert, Ph.D., et al.
The Future of DSM: A Strategic Vision for Incorporating Socioeconomic, Cultural, and Environmental Determinants and IntersectionalityMilton L. Wainberg, M.D., et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample May 01, 2026

Show notes

Dr. Eduardo Butelman (Icahn School of Medicine at Mount Sinai, New York) joins AJP Audio to discuss the varying incidence of psychiatric comorbidities across patients diagnosed with substance use disorders. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to discuss the rest of the May issue, which includes a discussion on the future of the DSM.

00:53 Butelman interview
02:23 Mechanisms of difference between males and females
04:04 Patterns of response between males and females in substance use disorders
05:54 Implications for research into sex-based differences
07:33 Racial and ethnic variations in findings
09:30 Limitations
10:46 Immediate clinical implications?
12:09 Further research
13:18 Kalin interview
13:38 Butelman et al.
17:11 Hinojosa et al.
22:49 van Rooij et al.
26:06 The future of DSM

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

April 2026: Mobile Health for Alcohol Use Assessment: Longitudinal Effects of Breathalyzer Self-Monitoring in Everyday Contexts Apr 01, 2026

Show notes

Yang Lu, M.S., and Catharine E. Fairbairn, Ph.D. (University of Illinois, Urbana-Champaign) join AJP Audio to discuss the longitudinal effects of the use of personal alcohol breathalyzers in a natural setting on alcohol usage. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to discuss the rest of the April issue, which focuses on subjects related to substance use disorders.

00:57 What did you discover about the long term effects of using a personal blood alcohol monitor?
03:12 Do health monitoring devices actually change behaviors?
04:10 What did your cohort look like?
08:49 Disparate impact of monitoring on heavy drinkers and light drinkers
11:36 Clinical implications
14:34 Limitations
15:46 Avenues for further research
18:39 Kalin interview
18:46 Lu et al.
24:00 Wittekind et al.
29:50 Nicholson et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

March 2026: Primary Prevention of PTSD Symptoms in Combat-Deploying Soldiers Using Attention Bias Modification: A Randomized Controlled Trial Mar 01, 2026

Show notes

Chelsea Dyan Gober Dykan, M.A. (Tel Aviv University, Israel), joins AJP Audio to discuss a study looking at two versions of attention bias modification with an eye towards a prophylactic impact on developing PTSD in a cohort of combat-bound soldiers. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to put the rest of the March issue into context.

00:57 Attention bias modifications
03:54 Response-time and gaze-contingent paradigms
05:05 Differences in efficacy between the two arms
08:06 Ethical considerations in investigating combat-bound soldiers
10:44 Controlling for combat experiences in studying PTSD
12:24 Duration of the effect
13:44 Limitations
15:03 Immediate clinical implications
16:22 Further research
17:05 Kalin interview
17:22 Dykan et al.
21:03 Kaul et al.
26:19 Kantrowitz et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

February 2026: Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial Feb 01, 2026

Show notes

Dr. Ian Kelleher (University of Edinburgh, Scotland) joins AJP Audio to discuss an emulated target trial looking at the prophylactic qualities of doxycycline, an antibiotic, in an adolescent population at risk to develop schizophrenia spectrum disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to put the rest of the issue into context.

00:53 Doxycycline and the risk of developing schizophrenia
04:03 Emulated target trials versus randomized control trials
06:43 Methods of action
09:24 Dosage and exposure levels for doxycycline
10:15 Immediate clinical applications
10:56 Limitations of the study
11:33 Future research
12:43 Kalin interview
13:00 Lång et al.
19:43 Zhao et al.
25:20 Metrik et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

Related Podcasts